Largest health care companies by total liabilities
Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.
UnitedHealth Group leads the 170 health care companies ranked by total liabilities, at NOK 2.02T, ahead of CVS Health (NOK 1.73T) and AbbVie (NOK 1.33T). Figures as of 19 Nov 2026, 14:43 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 170
- First
- UnitedHealth GroupNOK 2.02T
- Median
- NOK 29.6B
- Combined market value
- NOK 87.44T
- Countries
- 14
Market values as of .
All countries▾
Health Care▾
All categories▾
| # | Company | Total liabilities ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 101 | IDEXX LaboratoriesIDXX · Health Care | NOK 16.9B | NOK 529.6B | NOK 6,722.12 | 0.76% down | 1% up | ||
| 102 | InsuletPODD · Health Care | NOK 16.2B | NOK 95.2B | NOK 1,372.46 | 1.10% up | 55% down | ||
| 103 | Ascendis PharmaASND · Health Care | NOK 15.8B | NOK 171.8B | NOK 2,618.40 | 0.12% down | 29% up | ||
| 104 | Hims & Hers HealthHIMS · Health Care | NOK 15.7B | NOK 38.6B | NOK 164.77 | 0.35% down | 49% down | ||
| 105 | HaemoneticsHAE · Health Care | NOK 15.5B | NOK 54.1B | NOK 1,188.46 | 0.29% down | 64% up | ||
| 106 | InsmedINSM · Health Care | NOK 14.8B | NOK 257.5B | NOK 1,173.68 | 1.02% up | 40% down | ||
| 107 | Medpace HoldingsMEDP · Health Care | NOK 14.7B | NOK 176B | NOK 6,292.12 | 0.30% up | 10% up | ||
| 108 | BioMarin PharmaceuticalBMRN · Health Care | NOK 14.6B | NOK 116.5B | NOK 601.70 | 1.00% up | 17% up | ||
| 109 | LivaNovaLIVN · Health Care | NOK 13.6B | NOK 50B | NOK 907.03 | 1.07% down | 77% up | ||
| 110 | Neurocrine BiosciencesNBIX · Health Care | NOK 13.4B | NOK 157.8B | NOK 1,558.53 | 1.32% down | 17% up | ||
| 111 | argenxARGX · Health Care | NOK 13.2B | NOK 571.6B | NOK 9,090.13 | 0.42% down | 2% up | ||
| 112 | HealthEquityHQY · Health Care | NOK 12.3B | NOK 77.9B | NOK 941.75 | 0.21% down | 3% down | ||
| 113 | MSA SafetyMSA · Health Care | NOK 11.5B | NOK 66.8B | NOK 1,733.00 | 0.68% up | 16% up | ||
| 114 | Lantheus HoldingsLNTH · Health Care | NOK 11B | NOK 64.8B | NOK 990.24 | 0.11% up | 90% up | ||
| 115 | Merit Medical SystemsMMSI · Health Care | NOK 10.7B | NOK 49.2B | NOK 821.89 | 1.37% down | 1% up | ||
| 116 | West Pharmaceutical ServicesWST · Health Care | NOK 10.6B | NOK 270.4B | NOK 3,882.17 | 0.92% down | 57% up | ||
| 117 | MiniMed GroupMMED · Health Care | NOK 9.9B | NOK 46.1B | NOK 163.80 | 0.59% down | 8% down | ||
| 118 | ImmunityBioIBRX · Health Care | NOK 9.7B | NOK 68.8B | NOK 64.68 | 0.45% down | 232% up | ||
| 119 | Arrowhead PharmaceuticalsARWR · Health Care | NOK 8.6B | NOK 59B | NOK 417.25 | 0.20% down | 13% up | ||
| 120 | RepligenRGEN · Health Care | NOK 8.2B | NOK 109.3B | NOK 1,709.67 | 2.10% up | 12% up | ||
| 121 | United TherapeuticsUTHR · Health Care | NOK 7.6B | NOK 236.4B | NOK 5,550.05 | 0.87% down | 22% up | ||
| 122 | Legend BiotechLEGN · Health Care | NOK 7.1B | NOK 30.3B | NOK 156.13 | 0.92% down | 41% down | ||
| 123 | Globus MedicalGMED · Health Care | NOK 7.1B | NOK 89.8B | NOK 677.63 | 0.93% down | 14% down | ||
| 124 | Revolution MedicinesRVMD · Health Care | NOK 7B | NOK 342.2B | NOK 1,582.19 | 2.08% up | 129% up | ||
| 125 | NateraNTRA · Health Care | NOK 6.7B | NOK 416.2B | NOK 2,870.55 | 2.25% up | 28% up | ||
| 126 | ExelixisEXEL · Health Care | NOK 6.6B | NOK 158.5B | NOK 649.70 | 1.90% down | 63% up | ||
| 127 | LifeStance Health GroupLFST · Health Care | NOK 6.6B | NOK 50.2B | NOK 132.13 | 1.05% down | 123% up | ||
| 128 | AlkermesALKS · Health Care | NOK 6.5B | NOK 76B | NOK 452.16 | 0.48% down | 66% up | ||
| 129 | Madrigal PharmaceuticalsMDGL · Health Care | NOK 6.4B | NOK 90.5B | NOK 3,893.76 | 0.86% up | 27% down | ||
| 130 | Axsome TherapeuticsAXSM · Health Care | NOK 5.8B | NOK 68.8B | NOK 1,307.65 | 0.63% up | 6% down | ||
| 131 | ChemedCHE · Health Care | NOK 5.4B | NOK 67.8B | NOK 5,232.35 | 1.37% down | 27% up | ||
| 132 | Caris Life SciencesCAI · Health Care | NOK 5.3B | NOK 55.9B | NOK 194.93 | 3.08% up | 19% down | ||
| 133 | Ligand PharmaceuticalsLGND · Health Care | NOK 5.3B | NOK 57.6B | NOK 2,879.86 | 0.59% down | 50% up | ||
| 134 | Mirum PharmaceuticalsMIRM · Health Care | NOK 5.1B | NOK 58.6B | NOK 898.11 | 0.13% up | 34% up | ||
| 135 | Travere TherapeuticsTVTX · Health Care | NOK 4.8B | NOK 47B | NOK 489.40 | 0.45% up | 45% up | ||
| 136 | Bio-TechneTECH · Health Care | NOK 4.6B | NOK 110.8B | NOK 705.14 | 0.05% down | 24% up | ||
| 137 | Roivant SciencesROIV · Health Care | NOK 4B | NOK 274.5B | NOK 378.80 | 0.85% up | 91% up | ||
| 138 | TG TherapeuticsTGTX · Health Care | NOK 4B | NOK 96.9B | NOK 641.41 | 0.03% up | 117% up | ||
| 139 | PenumbraPEN · Health Care | NOK 3.9B | NOK 122.6B | NOK 3,109.31 | 0.04% up | 15% up | ||
| 140 | GRAILGRAL · Health Care | NOK 3.3B | NOK 46.8B | NOK 1,041.69 | 5.21% up | 19% up | ||
| 141 | CRISPR TherapeuticsCRSP · Health Care | NOK 3.3B | NOK 38B | NOK 391.89 | 0.55% up | 18% down | ||
| 142 | VaxcytePCVX · Health Care | NOK 3.1B | NOK 90.1B | NOK 569.21 | 0.30% up | 23% up | ||
| 143 | Cogent BiosciencesCOGT · Health Care | NOK 2.9B | NOK 47.2B | NOK 271.54 | 0.68% up | 20% down | ||
| 144 | Adaptive BiotechnologiesADPT · Health Care | NOK 2.8B | NOK 45.8B | NOK 283.15 | 2.59% up | 74% up | ||
| 145 | 10x GenomicsTXG · Health Care | NOK 2.4B | NOK 76.1B | NOK 578.47 | 4.52% up | 247% up | ||
| 146 | GlaukosGKOS · Health Care | NOK 2.3B | NOK 134.9B | NOK 2,278.98 | 0.82% up | 145% up | ||
| 147 | Rhythm PharmaceuticalsRYTM · Health Care | NOK 2B | NOK 79.6B | NOK 1,147.59 | 0.59% down | 18% up | ||
| 148 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | NOK 1.9B | NOK 72.4B | NOK 920.85 | 0.10% down | 129% up | ||
| 149 | Kodiak SciencesKOD · Health Care | NOK 1.9B | NOK 62.2B | NOK 950.38 | 0.19% up | 399% up | ||
| 150 | Corcept TherapeuticsCORT · Health Care | NOK 1.8B | NOK 71.9B | NOK 657.17 | 0.04% down | 10% down | ||
| 151 | Twist BioscienceTWST · Health Care | NOK 1.6B | NOK 78.7B | NOK 1,154.04 | 2.28% up | 346% up | ||
| 152 | Kymera TherapeuticsKYMR · Health Care | NOK 1.6B | NOK 99.9B | NOK 1,170.23 | 0.38% down | 87% up | ||
| 153 | Scholar Rock HoldingSRRK · Health Care | NOK 1.5B | NOK 57.2B | NOK 469.23 | 0.80% up | 26% up | ||
| 154 | BillionToOneBLLN · Health Care | NOK 1.5B | NOK 42.9B | NOK 897.63 | 1.11% up | 4% down | ||
| 155 | ABIVAXABVX · Health Care | NOK 1.4B | NOK 71.1B | NOK 812.43 | 0.07% down | 32% down | ||
| 156 | Krystal BiotechKRYS · Health Care | NOK 1.1B | NOK 90.6B | NOK 3,058.25 | 0.00% up | 54% up | ||
| 157 | Definium TherapeuticsDFTX · Health Care | NOK 1B | NOK 39.2B | NOK 285.99 | 1.27% up | 168% up | ||
| 158 | ImmunovantIMVT · Health Care | NOK 1B | NOK 66.6B | NOK 321.77 | 0.03% up | 46% up | ||
| 159 | Summit TherapeuticsSMMT · Health Care | NOK 895.3M | NOK 80.7B | NOK 100.95 | 0.86% down | 36% down | ||
| 160 | ErascaERAS · Health Care | NOK 688.4M | NOK 48.2B | NOK 137.42 | 2.98% up | 395% up | ||
| 161 | Spyre TherapeuticsSYRE · Health Care | NOK 606.5M | NOK 93.3B | NOK 982.10 | 0.19% down | 332% up | ||
| 162 | Praxis Precision MedicinesPRAX · Health Care | NOK 579.6M | NOK 86.9B | NOK 3,110.08 | 5.08% up | 86% up | ||
| 163 | HeartflowHTFL · Health Care | NOK 570.3M | NOK 40.1B | NOK 455.99 | 2.46% up | 66% up | ||
| 164 | Protagonist TherapeuticsPTGX · Health Care | NOK 518.6M | NOK 80.5B | NOK 1,233.70 | 0.04% up | 51% up | ||
| 165 | CG OncologyCGON · Health Care | NOK 378.1M | NOK 70.2B | NOK 786.49 | 1.37% up | 97% up | ||
| 166 | Dianthus TherapeuticsDNTH · Health Care | NOK 363.9M | NOK 47.2B | NOK 838.18 | 2.92% up | 108% up | ||
| 167 | Edgewise TherapeuticsEWTX · Health Care | NOK 294.3M | NOK 43.3B | NOK 395.18 | 1.50% down | 86% up | ||
| 168 | Oruka TherapeuticsORKA · Health Care | NOK 161.8M | NOK 63.5B | NOK 936.56 | 0.87% up | 255% up | ||
| 169 | Belite BioBLTE · Health Care | NOK 97.7M | NOK 62B | NOK 1,527.45 | 0.82% up | 43% up | ||
| 170 | VeradermicsMANE · Health Care | NOK 88.8M | NOK 51.5B | NOK 1,221.41 | 0.84% up | 231% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total liabilities is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Where a company reports no total-liabilities line, it is worked out as assets less equity. Sums are converted from US dollars at today's exchange rate (1 USD = 9.6978 NOK).
Questions and answers
Which health care companies rank first by total liabilities?
UnitedHealth Group (NOK 2.02T), CVS Health (NOK 1.73T) and AbbVie (NOK 1.33T) are the top three of the 170 health care companies ranked by total liabilities as of 19 Nov 2026, 14:43 UTC.
How many health care companies are in this ranking?
170 are ranked by total liabilities.
What are these health care companies worth together?
The 170 health care companies ranked by total liabilities have a combined market value of NOK 87.44T as of 19 Nov 2026, 14:43 UTC.
What does ranking by total liabilities measure?
Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest health care companies by total liabilities”, data as of 19 November 2026. https://funkfolio.com/companies/sector/health-care?by=total-liabilities
Underlying data: Yahoo Finance; SEC EDGAR.